Presentation TCT 2012 Initiating a Renal Denervation Program Presenter: George Dangas October 25, 2012
Presentation TCT 2012 What's Known and Not Known About Renal Denervation for Hypertension: Critical Appraisal of the Clinical Data Presenter: Deepak Bhatt October 24, 2012
Presentation TCT 2012 Vincristine Local Delivery for Renal Artery Denervation Presenter: Christodoulos Stefanadis October 24, 2012
Presentation TCT 2012 Translational Medicine and Renal Denervation: Preclinical Animal Models and Histoanatomy Presenter: Renu Virmani October 24, 2012
Presentation TCT 2012 Three-Year Results from SYMPLICITY HTN-1 and SYMPLICITY HTN-2: What the Data Do (and Don't) Tell Us Presenter: Michael Bohm October 24, 2012
Presentation TCT 2012 The Clinical Use of Renal Denervation Is Already Expanding Beyond Trial Indications: Insights from the German GREAT Registry Presenter: Felix Mahfoud October 24, 2012
Presentation TCT 2012 SYMPLICITY Results Are Too Good to Be True: That's Why We Need a Sham Trial Design! Presenter: Darrel Francis October 24, 2012
Presentation TCT 2012 Sympathetic Renal Denervation: 6 Month Results of the EnligHTN I Study (St. Jude Medical) Presenter: Vasilios Papademetriou October 24, 2012
Presentation TCT 2012 Sham Trials Are Burdensome and Introduce Their Own Errors! Presenter: Deepak Bhatt October 24, 2012
Presentation TCT 2012 Resistant Hypertension: Prevalence and Global Impact Presenter: Stefan Bertog October 24, 2012
Presentation TCT 2012 Renal Sympathetic Denervation as the "Ideal Target" for Refractory Hypertension: Anatomy and Pathophysiology Presenter: Michael Bohm October 24, 2012
Presentation TCT 2012 Renal Artery Stenting: What Are the Indications for Intervention in 2012? Presenter: Christopher White October 24, 2012
Presentation TCT 2012 Physiologic Rationale for Interventional Therapies in Hypertension Presenter: C. Venkata S. Ram October 24, 2012